Literature DB >> 15975507

Features of selective kinase inhibitors.

Zachary A Knight1, Kevan M Shokat.   

Abstract

Small-molecule inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction. Despite the widespread use of these reagents, there is little consensus about the biochemical criteria that define their potency and selectivity in cells. We discuss some of the features that determine the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.

Mesh:

Substances:

Year:  2005        PMID: 15975507     DOI: 10.1016/j.chembiol.2005.04.011

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  205 in total

1.  Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors.

Authors:  Kayode K Ojo; Eric T Larson; Katelyn R Keyloun; Lisa J Castaneda; Amy E Derocher; Krishna K Inampudi; Jessica E Kim; Tracy L Arakaki; Ryan C Murphy; Li Zhang; Alberto J Napuli; Dustin J Maly; Christophe L M J Verlinde; Frederick S Buckner; Marilyn Parsons; Wim G J Hol; Ethan A Merritt; Wesley C Van Voorhis
Journal:  Nat Struct Mol Biol       Date:  2010-05-02       Impact factor: 15.369

2.  A computational workflow for the design of irreversible inhibitors of protein kinases.

Authors:  Alberto Del Rio; Miriam Sgobba; Marco Daniele Parenti; Gianluca Degliesposti; Rosetta Forestiero; Claudia Percivalle; Pier Franco Conte; Mauro Freccero; Giulio Rastelli
Journal:  J Comput Aided Mol Des       Date:  2010-03-21       Impact factor: 3.686

3.  Protein kinase affinity reagents based on a 5-aminoindazole scaffold.

Authors:  Ratika Krishnamurty; Amanda M Brock; Dustin J Maly
Journal:  Bioorg Med Chem Lett       Date:  2010-10-21       Impact factor: 2.823

Review 4.  Finding a better path to drug selectivity.

Authors:  Yuko Kawasaki; Ernesto Freire
Journal:  Drug Discov Today       Date:  2011-08-02       Impact factor: 7.851

5.  Comprehensive characterization of the Published Kinase Inhibitor Set.

Authors:  Jonathan M Elkins; Vita Fedele; Marta Szklarz; Kamal R Abdul Azeez; Eidarus Salah; Jowita Mikolajczyk; Sergei Romanov; Nikolai Sepetov; Xi-Ping Huang; Bryan L Roth; Ayman Al Haj Zen; Denis Fourches; Eugene Muratov; Alex Tropsha; Joel Morris; Beverly A Teicher; Mark Kunkel; Eric Polley; Karen E Lackey; Francis L Atkinson; John P Overington; Paul Bamborough; Susanne Müller; Daniel J Price; Timothy M Willson; David H Drewry; Stefan Knapp; William J Zuercher
Journal:  Nat Biotechnol       Date:  2015-10-26       Impact factor: 54.908

6.  Discovery of Bivalent Kinase Inhibitors via Enzyme-Templated Fragment Elaboration.

Authors:  Frank E Kwarcinski; Michael E Steffey; Christel C Fox; Matthew B Soellner
Journal:  ACS Med Chem Lett       Date:  2015-07-13       Impact factor: 4.345

7.  Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α.

Authors:  Curtis A Thorne; Alison J Hanson; Judsen Schneider; Emilios Tahinci; Darren Orton; Christopher S Cselenyi; Kristin K Jernigan; Kelly C Meyers; Brian I Hang; Alex G Waterson; Kwangho Kim; Bruce Melancon; Victor P Ghidu; Gary A Sulikowski; Bonnie LaFleur; Adrian Salic; Laura A Lee; David M Miller; Ethan Lee
Journal:  Nat Chem Biol       Date:  2010-10-03       Impact factor: 15.040

8.  Development of a highly selective c-Src kinase inhibitor.

Authors:  Kristoffer R Brandvold; Michael E Steffey; Christel C Fox; Matthew B Soellner
Journal:  ACS Chem Biol       Date:  2012-06-04       Impact factor: 5.100

9.  Phosphorylation of p53 by TAF1 inactivates p53-dependent transcription in the DNA damage response.

Authors:  Yong Wu; Joy C Lin; Landon G Piluso; Joseph M Dhahbi; Selene Bobadilla; Stephen R Spindler; Xuan Liu
Journal:  Mol Cell       Date:  2013-11-27       Impact factor: 17.970

10.  A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation.

Authors:  Rachel M Sammons; Nicole A Perry; Yangmei Li; Eun Jeong Cho; Andrea Piserchio; Diana P Zamora-Olivares; Ranajeet Ghose; Tamer S Kaoud; Ginamarie Debevec; Chandra Bartholomeusz; Vsevolod V Gurevich; Tina M Iverson; Marc Giulianotti; Richard A Houghten; Kevin N Dalby
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.